English
2021 China New Design 2-(2-Methyl-5-nitroanilino)-4-(3-pyridyl)pyrimidine - 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4 Linagliptin Intermediate Purity ≥99.0% (HPLC) Factory – Ruifu Featured Image
  • 2021 China New Design 2-(2-Methyl-5-nitroanilino)-4-(3-pyridyl)pyrimidine - 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4 Linagliptin Intermediate Purity ≥99.0% (HPLC) Factory – Ruifu

2021 China New Design 2-(2-Methyl-5-nitroanilino)-4-(3-pyridyl)pyrimidine - 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4 Linagliptin Intermediate Purity ≥99.0% (HPLC) Factory – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

Our company sticks into the basic principle of "Quality is definitely the life of the business, and status may be the soul of it" for Rivaroxaban CAS 366789-02-8, Formula Weight 269.34, Molecular Formula C5H3ClO2S, We welcome new and old customers from all walks of life to contact us for future business relationships and mutual success!
2021 China New Design 2-(2-Methyl-5-nitroanilino)-4-(3-pyridyl)pyrimidine - 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4 Linagliptin Intermediate Purity ≥99.0% (HPLC) Factory – Ruifu Detail:

Manufacturer Supply, High Purity, Commercial Production
Chemical Name: 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine
CAS: 666816-98-4
Intermediate for Linagliptin (CAS: 668270-12-0)

Chemical Name 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine
Synonyms 8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1H-purine-2,6-dione; Linagliptin Intermediate C
CAS Number 666816-98-4
CAT Number RF-PI497
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C10H9BrN4O2
Molecular Weight 297.11
Melting Point 285℃
Brand Ruifu Chemical
Item Specifications
Appearance White to Off-White Powder
Water (K.F) ≤0.50%
Residue on Ignition ≤0.50%
Purity/Analysis Method ≥99.0% (HPLC)
Max Single Impurity ≤0.50%
Residual Solvents
Ethanol ≤5000ppm
DMF ≤3000ppm
Test Standard Enterprise Standard
Usage Intermediate for Linagliptin (CAS: 668270-12-0)

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

1

8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine (CAS: 666816-98-4) is an intermediate for Linagliptin (CAS: 668270-12-0). Linagliptin is an oral, highly selective inhibitor of dipeptidyl peptidase-4 and is the first agent of its class to be eliminated predominantly via a nonrenal route. Linagliptin is indicated for once daily use for the treatment of adults with type 2 diabetes mellitus. Linagliptin was approved by the U.S. FDA in May 2011 for the treatment of Type 2 diabetes along with diet and exercise.

Product detail pictures:

2021 China New Design 2-(2-Methyl-5-nitroanilino)-4-(3-pyridyl)pyrimidine - 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4 Linagliptin Intermediate Purity ≥99.0% (HPLC) Factory – Ruifu detail pictures

Related Product Guide:
All we do is always associated with our tenet " Customer first, Trust first, devoting on the food packaging and environmental protection for 2021 China New Design 2-(2-Methyl-5-nitroanilino)-4-(3-pyridyl)pyrimidine - 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4 Linagliptin Intermediate Purity ≥99.0% (HPLC) Factory – Ruifu , The product will supply to all over the world, such as: luzern, Islamabad, Bandung, By adhering to the principle of "human oriented, winning by quality", our company sincerely welcomes merchants from at home and abroad to visit us, talk business with us and jointly create a brilliant future.
    • This is a reputable company, they have a high level of business management, good quality product and service, every cooperation is assured and delighted!
    5 Stars By Bella from America - 2017.08.15 12:36
    Good quality and fast delivery, it's very nice. Some products have a little bit problem, but the supplier replaced timely, overall, we are satisfied.
    5 Stars By Ethan McPherson from Nairobi - 2018.12.22 12:52
    Write your message here and send it to us